Lupin acquires Australia's Southern Cross Pharma

As a part of the transaction, Lupin's Australia subsidiary Generic Health will gain access to over 60 registered products having sales of over $22 million.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2WsyMsG
via IFTTT